Measuring LNP Encapsulation Efficiency: Methods, Common Pitfalls, and a Guide to Interpreting Results

Why Encapsulation Efficiency Matters in LNP Development?

Encapsulation efficiency (EE%) is among the most frequently reported quality attributes of lipid nanoparticle formulations — yet it is also among the most frequently misinterpreted. In LNP development programs spanning mRNA vaccines, siRNA therapeutics, gene editing cargo, and protein replacement therapies, EE% serves as a gatekeeper metric: it determines whether a formulation batch proceeds to downstream characterization or is rejected outright. A formulation with 95% EE% conveys confidence that the costly nucleic acid payload has been successfully incorporated; a batch reporting 70% EE% signals that nearly one-third of the payload is unaccounted for and potentially contributing to off-target effects, aggregation, or immunogenicity.

The stakes are not merely academic. For mRNA-LNP vaccines, the difference between 85% and 95% encapsulation efficiency can translate into measurable differences in antigen expression, immune response magnitude, and dose-sparing potential. For siRNA-LNP therapeutics, suboptimal EE% means more free siRNA circulating in the bloodstream — a direct driver of renal clearance, nuclease degradation, and reduced gene-silencing potency. This resource provides a comprehensive guide to measuring LNP encapsulation efficiency: the core analytical methods, why different techniques produce different results, a decision framework for selecting the right method based on LNP type, the most common pitfalls that distort EE% readings, and a systematic approach to interpreting EE% data in the context of other critical quality attributes.

Core Methods for Measuring LNP Encapsulation Efficiency

LNP encapsulation efficiency can be measured by dye exclusion, physical separation, electrophoresis, amplification, spectroscopy, and emerging particle-level techniques. Because each method defines free and encapsulated payload differently, the resulting EE% depends on the analytical principle, sample preparation, cargo type, and potential matrix interference.

Fluorescence Dye Exclusion Assays

RiboGreen - RNA Detection

Principle: RiboGreen fluoresces strongly after binding accessible RNA. In matched sample aliquots, the untreated LNP dispersion provides the free RNA signal, while detergent disruption releases the encapsulated RNA for total RNA measurement. Calculation: EE% = [(total RNA − free RNA) / total RNA] × 100%. Advantages: High sensitivity, low sample consumption, and compatibility with 96- or 384-well screening. Limitations: Lipids may alter fluorescence or dye binding, membrane defects may expose internal RNA, and the method cannot distinguish intact RNA from accessible fragments. Matrix-matched controls are therefore essential.

PicoGreen - dsDNA Detection

Principle: PicoGreen applies the same dye-exclusion approach but preferentially detects double-stranded DNA. It is suitable for pDNA-LNPs and related DNA payloads. Advantages: High dsDNA selectivity, good sensitivity, and a convenient plate-based workflow. Limitations: It is less suitable for RNA and short oligonucleotides and remains susceptible to lipid interference, incomplete particle disruption, and matrix effects.

SYBR Green - Broad Nucleic Acid Detection

Principle: SYBR Green binds multiple nucleic acid classes and can support preliminary analysis of mixed or incompletely defined payloads. Advantages: Broad applicability, wide availability, and relatively low cost. Limitations: Limited discrimination between RNA and DNA, higher background, and formulation-dependent interference make it less suitable than payload-selective dyes for routine EE% measurement.

Size-Exclusion and Ion-Exchange Chromatography

Size-Exclusion Chromatography (SEC-HPLC)

Principle: Large LNPs are excluded from column pores and elute before smaller free nucleic acid species. UV or fluorescence detection is used to quantify the separated fractions. Calculation: EE% = [LNP-associated peak area / (LNP-associated + free nucleic acid peak areas)] × 100%, after response and recovery correction. Advantages: Physical separation reduces dye-accessibility artifacts and provides an orthogonal assessment of payload association. Limitations: Peak overlap, column adsorption, sample dilution, and incomplete recovery can affect quantification. Appropriate detection and mass-balance controls are required.

Anion-Exchange Chromatography (AEX-HPLC)

Principle: AEX separates species according to charge. Free nucleic acid binds to the positively charged stationary phase, while suitable LNP populations may pass through or display different retention behavior. Advantages: It can resolve free nucleic acid when dye-based assays are affected by lipid interference. Limitations: LNP surface charge may cause unexpected retention, so salt gradients, column chemistry, recovery, and sample compatibility must be optimized for each formulation.

Gel and Capillary Electrophoresis

Agarose Gel Electrophoresis

Principle: Free nucleic acid migrates through an agarose gel, whereas LNP-associated payload is mobility-restricted. Comparing untreated and disrupted samples provides a visual estimate of encapsulation. Advantages: Low cost, accessible equipment, and rapid qualitative assessment. Limitations: Band staining and densitometry are only semi-quantitative, with limited precision for small oligonucleotides, heterogeneous samples, and lipid-rich formulations.

Capillary Gel Electrophoresis with Laser-Induced Fluorescence Detection (CGE-LIF)

Principle: Nucleic acid species are separated in a polymer-filled capillary and detected by laser-induced fluorescence. Combined with controlled particle disruption or fraction preparation, CGE-LIF can quantify payload and evaluate nucleic acid integrity. Advantages: High resolution, low sample consumption, automated analysis, and simultaneous integrity information. Limitations: Specialized instrumentation and method-specific sample preparation make it more appropriate for detailed analytical studies than rapid formulation screening.

Ultrafiltration and Centrifugal Separation

Centrifugal Ultrafiltration

Principle: A selected membrane retains LNPs while free nucleic acid passes into the filtrate for separate quantification. Calculation: EE% = [1 − (recovered free nucleic acid / measured total nucleic acid)] × 100%. Advantages: Simple equipment, flexible downstream detection, and no requirement for a dye-exclusion measurement. Limitations: Free nucleic acid may adsorb to the membrane, while excessive centrifugal stress may destabilize LNPs. Recovery across the filtrate, retentate, and membrane should be verified for each formulation.

qPCR, RT-qPCR, and Spectroscopic Quantification

qPCR (DNA) / RT-qPCR (RNA)

Principle: Following separation or controlled particle disruption, sequence-specific amplification quantifies free and total payload. RNA requires reverse transcription before qPCR. Calculation: EE% = [1 − (free copies / total copies)] × 100%. Advantages: High sensitivity and target-sequence specificity, particularly when payload concentrations are low. Limitations: Amplification confirms the target region rather than full-length integrity. Extraction, reverse transcription, primer efficiency, and matrix inhibition must be evaluated.

UV-Vis Absorbance (A₂₆₀)

Principle: Nucleic acid concentration is estimated from absorbance at 260 nm using the Beer-Lambert relationship. Advantages: Rapid, reagent-free analysis with minimal sample volume. Limitations: UV absorbance cannot distinguish free from encapsulated payload without separation. Intact LNPs and aggregates also scatter light, while detergents and buffer components may contribute to the signal. Validated disruption, extraction, and matched blanks are required.

Fluorometric Quantification

Principle: Selective fluorescent probes quantify RNA or DNA against calibration standards. Advantages: Greater sensitivity and nucleic acid selectivity than UV absorbance, especially at low concentrations. Limitations: Fluorometry alone does not distinguish free from encapsulated payload. It must be combined with dye exclusion, particle disruption, or physical separation and evaluated for lipid-related matrix effects.

Emerging LNP Encapsulation Efficiency Methods

Emerging techniques may provide particle-level, structural, or multidimensional information beyond routine bulk EE% assays. Most are best used as orthogonal development tools rather than standalone routine methods.

Single-Particle ICP-MS (spICP-MS)

Principle: Elemental signals are measured from individual particles passing through an inductively coupled plasma. Phosphorus-sensitive analysis may support assessment of phosphate-containing LNP components. Advantages: Single-particle detection without fluorescent labeling. Limitations: Lipids and nucleic acids may both contribute phosphorus, so nucleic acid loading cannot be assigned without suitable elemental controls and validated correlations.

Cryo-Electron Microscopy (Cryo-EM)

Principle: Vitrified LNPs are imaged to examine particle morphology, internal structure, and electron-density distribution. Advantages: Direct structural observation can reveal heterogeneous, multilamellar, or compartmentalized particles. Limitations: Cryo-EM is low-throughput and primarily qualitative for encapsulation. Electron-dense internal regions cannot automatically be assigned to nucleic acid without supporting evidence.

Asymmetric Flow Field-Flow Fractionation (AF4)

Principle: Particles are separated by hydrodynamic behavior in an open channel under perpendicular cross-flow. Advantages: Gentle, stationary-phase-free separation reduces column interaction and can accommodate larger particles and aggregates. Coupling with light-scattering and UV detectors provides complementary size and concentration data. Limitations: Recovery, membrane interaction, cross-flow conditions, and detector sensitivity require extensive optimization.

Two-Dimensional Liquid Chromatography (AEX × IP-RPLC)

Principle: The first dimension separates free nucleic acid from the LNP-associated fraction, while the second resolves released RNA according to chromatographic behavior related to size and composition. Advantages: EE% and RNA quality information may be obtained within one analytical workflow. Limitations: High method complexity, extended analysis time, interdimension compatibility, and recovery requirements limit routine throughput.

Surface Plasmon Resonance (SPR)

Principle: Capture-probe binding is detected through changes in refractive index at the sensor surface. Accessible nucleic acid can interact readily, while particle-associated payload may show reduced accessibility. Advantages: Label-free, real-time assessment of binding and accessibility. Limitations: Results depend on probe design, particle-surface interactions, and mass-transport effects. SPR is better suited to mechanistic studies than direct routine EE% quantification.

Table 1. Summary of LNP Encapsulation Efficiency Measurement Methods.

Why EE% Results Differ Across Measurement Methods?

EE% is an operationally defined result. A dye exclusion assay measures nucleic acid that is inaccessible to the dye before particle disruption. SEC measures material that travels with the nanoparticle fraction. Ultrafiltration measures material retained by a selected membrane. A nuclease protection assay measures cargo protected from enzymatic digestion. These definitions overlap, but they are not identical.

Surface-adsorbed cargo illustrates the difference. It may be dye-accessible and therefore counted as free, co-elute with LNPs during SEC and therefore appear associated, or remain on an ultrafiltration membrane and falsely increase the apparent encapsulated fraction. Incomplete LNP disruption can lower the measured total payload, while free-cargo adsorption can lower the measured free fraction; both errors inflate EE%. Dilution-induced leakage can produce the opposite effect.

Cross-method agreement should be evaluated against predefined criteria rather than expected to be exact. When results diverge, review the measurand, preparation, blank correction, recovery, dilution, separation boundary, and detector response. A rapid assay paired with a physically different separation or protection method is often the most defensible strategy for LNP encapsulation efficiency testing.

Selecting the Right EE% Method for Different LNP Types

There is no universal "best" method for EE% determination. The optimal choice depends on three interconnected factors: nucleic acid cargo type, lipid composition, and the physical state of the formulation.

Method Selection by Nucleic Acid Cargo

mRNA molecules (1,000-5,000 nt) are large enough for reliable RiboGreen discrimination between free and encapsulated species; the main precaution is using identical modified mRNA for the standard curve. siRNA duplexes (~21 bp) are small enough that gel electrophoresis resolution is limiting, and the cationic lipids common in siRNA-LNP formulations pose RiboGreen interference risk — a lipid-only blank control is essential. pDNA payloads (3-10 kb) demand PicoGreen rather than RiboGreen for dsDNA specificity, and lysis may require both 2% a compatible nonionic detergent and proteinase K for multi-lamellar structures. saRNA (9-12 kb) has reduced RiboGreen binding efficiency per nucleotide due to its extreme size, making RT-qPCR with replicase-targeting primers the more reliable first-line method. For short oligonucleotides (ASO, miRNA) below ~30 nt, AEX-HPLC is preferred because RiboGreen binding to very short nucleic acids is weak and variable.

Table 2. EE Method Selection by Nucleic Acid Cargo Type.

Method Selection by Lipid Composition

Ionizable lipid LNPs (SM-102, ALC-0315, DLin-MC3-DMA) represent the most forgiving case: near-neutral surface charge at pH 7.4 minimizes RiboGreen interference, making the fluorescence dye exclusion with SEC-HPLC confirmation orthogonal pair the standard workflow — just ensure complete ethanol removal. Permanent cationic lipid LNPs (DOTAP, DC-Chol, DOTMA) are the most challenging: strong positive charge competes with RiboGreen for nucleic acid binding, so AEX-HPLC is the preferred method; RiboGreen should only be used after rigorous blank-LNP validation. High-PEG content LNPs (>3 mol% PEG-lipid) create a unique ambiguity where the PEG layer may loosely sequester nucleic acid at the particle surface — a nuclease challenge assay provides the clearest distinction between surface-bound and core-encapsulated payload. DSPC-containing LNPs require only lysis condition verification, as DSPC increases membrane stability; confirming the fluorescence signal plateaus after detergent addition is the critical quality check.

Table 3. EE Method Selection by Lipid Composition.

Method Selection by LNP Physical State

Lyophilized formulations require immediate post-reconstitution EE% measurement and comparison with pre-lyophilization values to quantify process-induced leakage. High-concentration formulations (>1 mg/mL RNA) suffer from viscosity-related pipetting errors and concentrated lipid light scattering — dilution to standard assay range while maintaining buffer composition, with preference for HPLC methods, is recommended. Serum- or plasma-containing samples present protein interference: serum proteins bind free nucleic acid and compete with detection reagents; proteinase K pre-treatment or SEC-based separation resolves this. Ligand-modified LNPs (antibody, peptide, or aptamer conjugates) have increased hydrodynamic size that can clog ultrafiltration membranes and SEC columns — AF4 provides the gentlest separation alternative. Aggregated or freeze-thaw-damaged LNPs require special handling: aggregates cause non-representative sampling, while freeze-thaw cycles cause progressive leakage; using single-use aliquots and documenting freeze-thaw history are essential practices.

Table 4. EE Method Selection by LNP Physical State.

Common Pitfalls and Best Practices in LNP Encapsulation Measurement

LNP encapsulation efficiency is an operationally defined measurement. The reported value depends on how free, surface-associated, and internally encapsulated nucleic acids are distinguished. Errors in calculation, particle disruption, separation, sample handling, or calibration can therefore produce apparently high or low EE% values that do not accurately represent the formulation.

I. Definition and Calculation Pitfalls

• Confusing encapsulation efficiency with total nucleic acid recovery: EE% describes the proportion of measurable nucleic acid classified as encapsulated, whereas total recovery compares the nucleic acid measured after formulation with the amount initially added. A sample can show an EE% above 90% while having poor total recovery if a substantial amount of nucleic acid was degraded, adsorbed to equipment, or lost during processing. Reporting EE% without total recovery can therefore conceal formulation or process losses.
• Using the theoretical input as the total nucleic acid value: The denominator used to calculate EE% should be the total nucleic acid measured after complete disruption of an aliquot from the same LNP sample. It should not be the theoretical input amount. Using the input amount can incorrectly classify nucleic acid lost during preparation as encapsulated and produce an artificially high result.

EE% = [1 - (Measured Free Nucleic Acid / Measured Total Nucleic Acid)] × 100%

Free and total measurements should be corrected for sample volume and dilution factors. Total payload recovery should be calculated and reported separately:

Total Payload Recovery (%) = (Measured Total Nucleic Acid / Input Nucleic Acid) × 100%

II. Fluorescence Dye Assay Pitfalls

Fluorescence dye exclusion assays are widely used for routine LNP analysis, but their apparent simplicity can obscure several important sources of bias.

• Incomplete LNP disruption: Insufficient detergent concentration or incubation time may leave part of the encapsulated nucleic acid inaccessible to the dye. This lowers the measured total nucleic acid signal and will generally cause EE% to be underestimated when the free-payload signal remains unchanged. Disruption conditions should be optimized by increasing the detergent concentration or incubation time until the total signal reaches a stable plateau.
• Unsuitable dye selection or concentration range: Dye chemistry should match the nucleic acid class. PicoGreen is generally more appropriate for double-stranded DNA, whereas RNA-selective dyes are more suitable for mRNA, saRNA, and siRNA. Samples above the validated linear range may exhibit detector saturation, inner-filter effects, or fluorescence quenching. Serial dilution should confirm that the calculated concentration remains proportional to dilution.
• Direct interference from lipid components: Some ionizable or cationic lipids can change dye binding, quench fluorescence, or create background signals. Suppression of the free-nucleic-acid signal can produce an artificially high EE%. Blank LNP controls and matrix-matched spike recovery experiments should be used to identify lipid-related interference. Dilution may reduce interference, provided the nucleic acid concentration remains within the assay range.
• Ignoring particle light scattering: Concentrated or aggregated LNPs can scatter excitation and emission light, increasing the apparent fluorescence baseline or distorting signal intensity. An elevated free-payload signal may result in an underestimated EE%. Blank-particle subtraction and dilution-linearity testing are especially important for concentrated or turbid samples.
• Inconsistent treatment of surface-associated nucleic acid: Dye-accessible nucleic acid adsorbed to the LNP surface is usually counted as unencapsulated, even though it is not freely dissolved in the continuous phase. Conversely, sterically shielded surface-associated nucleic acid may remain inaccessible to the dye and be counted as encapsulated. Reports should therefore define whether EE% represents internally encapsulated, dye-inaccessible, particle-associated, or nuclease-protected payload.

III. Separation Method Pitfalls

Ultrafiltration, centrifugal separation, and size-exclusion chromatography physically separate free nucleic acid from LNP-associated material. Their results depend strongly on recovery and separation performance.

• Membrane adsorption during ultrafiltration: Free nucleic acids, particularly long RNA molecules, can adsorb nonspecifically to the membrane or device wall. The resulting reduction in nucleic acid measured in the filtrate produces an artificially high EE%. Free-payload recovery controls, suitable low-binding membranes, device preconditioning, and analysis of membrane rinses can help identify this loss.
• LNP disruption during centrifugal processing: Excessive centrifugal force, extended processing, concentration polarization, or unsuitable membrane chemistry may destabilize LNPs and release encapsulated nucleic acid. The increased free fraction can lead to an underestimated EE%. Particle size, PDI, and payload leakage should be checked before and after separation.
• Poor SEC peak resolution: LNP peak tailing or partial overlap between LNP and free-nucleic-acid peaks can make fraction assignment uncertain. Incorrect peak integration may classify free nucleic acid as particle-associated material or exclude part of the LNP fraction.
• Dilution and recovery losses during SEC: SEC can substantially dilute LNP fractions, placing the nucleic acid concentration near or below the quantification limit. Nucleic acid and LNPs may also adsorb to the column. Both LNP-associated and free fractions should be analyzed, and the recovered mass should be compared with the injected amount.

IV. UV Absorbance Measurement Pitfalls

• Overestimating nucleic acid because of LNP scattering: Intact LNPs scatter light at 260 nm, meaning that even a nucleic-acid-free blank formulation can produce an apparent A₂₆₀ signal. Directly using the A₂₆₀ value of an intact LNP dispersion may therefore substantially overestimate nucleic acid concentration. The payload should be measured after validated particle disruption or extraction, or the contribution from an appropriate blank LNP formulation should be carefully evaluated and subtracted.
• Ignoring absorbance from other sample components: Detergents, residual solvents, reducing agents such as DTT, and certain buffer components may contribute to absorbance at or near 260 nm. Blanks should contain the same buffer, detergent, and processing reagents at concentrations matching those in the analyzed sample.
• Using UV absorbance below its practical quantification range: UV measurement has lower sensitivity than fluorescence-based or amplification-based methods. At low nucleic acid concentrations, scattering and baseline variation may contribute more to the signal than the payload itself. Dilution and extraction losses should therefore be balanced against the method's quantification capability.

V. Sample Handling Pitfalls

• Nuclease contamination: RNase or DNase contamination can preferentially degrade exposed free nucleic acid before measurement. A reduced free-payload signal may create a false impression of nearly complete encapsulation. Nuclease-controlled reagents, consumables, work areas, and handling procedures should be used throughout sample preparation. A suitable nuclease inhibitor may be considered when compatible with the selected assay.
• Payload leakage caused by inappropriate storage: Repeated freeze-thaw cycles, prolonged storage under unsuitable conditions, or extended handling at room temperature can damage LNP structure and release nucleic acid. A lower EE% measured after storage may therefore reflect handling-induced leakage rather than the initial formulation result. Storage time, temperature, thawing, and sampling procedures should be standardized.
• Aggregation and sedimentation: Aggregated LNPs can make the sample composition spatially nonuniform, causing small aliquots to be unrepresentative. Aggregates may also produce abnormal scattering, filtration, and fluorescence behavior. Samples should be visually inspected, mixed using a validated low-stress procedure, and evaluated for particle size and PDI when EE% results are highly variable.

VI. Standard Curve and Matrix Effect Pitfalls

• Using a calibration matrix that does not match the sample: A standard curve prepared in water or a simple buffer may not represent an LNP sample containing lipids, salts, sugars, residual solvent, and detergent. Differences in pH, ionic strength, lipid concentration, and detergent content can change dye binding and fluorescence response. Standards should be prepared in a matrix-matched blank formulation that reproduces the composition of the corresponding free or disrupted sample. Standard addition can be used when an appropriate blank matrix is unavailable.
• Assuming a constant dye response for every nucleic acid: Fluorescence response can vary with nucleic acid length, sequence, secondary structure, strandedness, and chemical modification. A calibration curve prepared from a short unmodified RNA may not accurately quantify a long or modified mRNA payload. The same nucleic acid material used in the LNP formulation, or a qualified representative material, should be used for calibration whenever possible.
• Failing to verify recovery and dilutional parallelism: A calibration curve with acceptable linearity does not prove that the sample matrix is free from interference. Spike recovery should be assessed at multiple concentration levels, and serially diluted samples should produce proportional results. Failure of recovery or dilutional parallelism indicates that the matrix, disruption conditions, or analytical range requires further optimization.

How to Interpret LNP Encapsulation Efficiency Results?

An EE% number stripped of context can be misleading. The sections below provide a structured framework for interpreting EE% data alongside recovery, absolute thresholds, method-specific biases, other critical quality attributes, and stability trends.

I. Interpreting EE% Together with Total Payload Recovery

EE% alone can be deceptive. Total nucleic acid recovery must always be calculated alongside it:

Total nucleic acid recovery (%) = (measured total nucleic acid after lysis / theoretical input nucleic acid) × 100%

The combination of these two values enables clear diagnosis:

Table 5. Diagnostic Interpretation of EE% and Total Nucleic Acid Recovery Combinations.

Conclusion: Only "high EE% + high recovery" represents a truly good result. Every EE% report should include the corresponding recovery value.

II. Interpreting Absolute EE% Values

For commercial or clinical-stage mRNA-LNP formulations, the target is typically EE% ≥ 90%.

EE% ≥ 95%: Generally considered adequate encapsulation. Free nucleic acid is minimal. However, caution is warranted — verify that this is not a false-high reading caused by method artifacts such as lipid interference with the fluorescent dye (see pitfalls section).

85% ≤ EE% < 90%: A borderline state requiring careful evaluation. If batch-to-batch consistency is acceptable and downstream purification can remove the free nucleic acid fraction, this range may be tolerated. However, for demanding in vivo studies, the free nucleic acid may trigger stronger innate immune responses or toxicity.

EE% < 85%: Generally considered encapsulation failure or a substandard process. A large amount of free nucleic acid not only represents wasted mRNA but may also exacerbate particle aggregation, rapid in vivo clearance, and off-target effects.

Key insight: EE% measures quantity, but interpretation must connect to function. An LNP with 100% EE% may contain mRNA that was severely fragmented during processing — the fragments are encapsulated but incapable of producing functional protein. High EE% does not equal high potency. Always pair EE% with an mRNA integrity measurement such as capillary electrophoresis.

III. Interpreting EE% Alongside Other Critical Quality Attributes

EE% viewed in isolation has limited meaning. It must be placed within the broader LNP characterization profile.

EE% vs. particle size and PDI: High EE% + small size (50-100 nm) + low PDI (<0.2) is the ideal profile — nucleic acid is efficiently condensed and packaged into compact, uniform particles. High EE% + large size (>150 nm) + high PDI is a danger signal. This may not represent true encapsulation but rather nucleic acid-induced liposome aggregation, with nucleic acid trapped within clusters of fused particles. Such formulations have extremely poor stability and unpredictable in vivo behavior.

EE% vs. zeta potential: High EE% + near-neutral potential (−10 to +10 mV) is the typical result for ionizable lipid LNPs — the nucleic acid is fully neutralized and buried internally. High EE% + highly positive potential (>+20 mV) suggests abundant cationic lipid exposed on the surface, implying that nucleic acid is incompletely encapsulated and partially present as surface electrostatic complexes. Such particles may exhibit greater cytotoxicity and shorter in vivo circulation times.

EE% vs. mRNA integrity: High EE% + low integrity indicates that shear forces or heating during processing caused mRNA fragmentation. Although the fragments are encapsulated, the product is non-functional. This is a hidden cause of process failure.

BOC Sciences Support for LNP Encapsulation Analysis

BOC Sciences provides integrated lipid nanoparticle characterization for formulation, process, batch, purification, and stability studies. We define the measurand, select a cargo- and matrix-appropriate method, and establish separation or disruption conditions, calibration, dilution, recovery controls, and orthogonal confirmation. Results are interpreted with size, PDI, zeta potential, morphology, integrity, and function as needed.

We investigate unexpectedly high EE%, disagreement between methods, low recovery, concentration effects, membrane losses, peak overlap, and leakage. When data identify a formulation or process limitation, LNP encapsulation efficiency optimization can evaluate lipid ratios, N/P ratio, mixing, pH, concentration, and downstream processing.

Table 6. BOC Sciences Services for LNP Encapsulation Efficiency Analysis and Optimization.